FIELD: medicine.
SUBSTANCE: what is described is a method of the one-step introduction of single-dose ibuprofen. The method consists in providing a mammal with an initial dose of 200 mg to 400 mg of immediate release ibuprofen and a second dose of 100 mg to 200 mg of prolonged release ibuprofen. Said prolonged release second dose is delivered for approximately 2 to 10 hours following the immediate release immediate dose. The immediate release immediate dose and the prolonged release second dose ensures pain relief for a 12-hour period.
EFFECT: method for the ibuprofen administration according to the invention provides a higher therapeutic effect as compared to the common dosing regimens.
5 cl, 4 dwg, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS | 2008 |
|
RU2471480C2 |
| CONTROLLED RELEASE ANALGETIC SUSPENSIONS | 2004 |
|
RU2386434C2 |
| TWO-LAYER COMPOSITION FOR CONTINUOUS RELEASE OF ACETAMINOPHEN AND TRAMADOL | 2008 |
|
RU2469718C2 |
| IMMEDIATE RELEASE COMPOSITIONS | 2010 |
|
RU2541807C2 |
| MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
| EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF | 2013 |
|
RU2599017C2 |
| COMBINED DELIVERY SYSTEM WITH IMMEDIATE/SUSTAINED RELEASE OF MEDICINAL AGENTS WITH SHORT PERIOD OF HALF-LIFE, INCLUDING FOR REMOGLIFLOZIN | 2011 |
|
RU2596787C2 |
| ORAL DOSAGE FORMS OF TOFACITINIB WITH CONTINUOUS RELEASE | 2014 |
|
RU2790166C2 |
| EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF | 2012 |
|
RU2603471C2 |
| COMPOSITION AS MULTIPLE PARTICLES WITH MODIFIED RELEASE | 1999 |
|
RU2236847C2 |
